Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder

Published:2001-03 Issue:3 Volume:57 Page:414-421
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Van Kerrebroeck Philip,Kreder Karl,Jonas Udo,Zinner Norm,Wein Alan

Publisher

Elsevier BV

Subject

Urology

Reference24 articles.

1. The Overactive Bladder;Abrams,1998

2. The overactive bladder;Andersson;Urology,1997

3. Factors involved in the success of antimuscarinic treatment;Abrams;BJU Int,1999

4. Oxybutynin;Yarker;Drugs Aging,1995

5. The mechanism of action of tolterodine;Nilvebrant;Rev Contemp Pharmacother,2000

Cited by 409 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the efficacy and complications of tolterodine and α-adrenergic receptor blockers in improving ureteral stent-related symptoms: A systematic review and meta-analysis;PLOS ONE;2024-05-03

2. Maternal distress during the COVID-19 outbreak: A socio-ecological perspective;PLOS ONE;2024-05-03

3. Anticholinergic burden of medications is associated with dry mouth and reflected in minor labial gland secretion;Archives of Oral Biology;2023-12

4. Intracellular signaling pathways of muscarinic acetylcholine receptor-mediated detrusor muscle contractions;American Journal of Physiology-Renal Physiology;2023-11-01

5. Comparative assessment of efficacy and safety of approved oral therapies for overactive bladder: a systematic review and network meta-analysis;International braz j urol;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP